Abstract
Cholesteryl ester transfer protein (CETP) is one of the key proteins in reverse cholesterol transport (RCT). The role of CETP in atherosclerosis remains controversial. In this study we investigated the associations between polymorphisms of CETP (mutations in intron 14 and exon 15, and Taq1B), hepatic lipase (C-514T), lipoprotein lipase (PvuII and HindIII), and ATP-binding cassette transporter 1 (R219K) loci and longevity in 256 centenarians and 190 healthy younger controls. Although heterozygous CETP deficiency and the B2 allele of the Taq1B polymorphism was consistently associated with higher HDL-C concentrations both in centenarians and controls, the allelic frequencies of those polymorphisms did not differ between the two groups. The allelic frequencies of other gene polymorphisms in RCT were not different between the two groups. Centenarians with lipoprotein lipase P(−/−) genotype had significantly higher HDL-C concentration than those with P(−/+) or with P(+/+), in contrast, there was no such a relationship among controls. In stepwise multiple regression analysis, serum albumin, CETP deficiency and lipoprotein lipase PvuII genotype were independently associated with HDL-C in centenarians. Sex, CETP deficiency, and the Taq1B genotype were also independently associated with HDL-C; however, lipoprotein lipase PvuII genotype had no significant effect on their HDL-C in controls. In conclusion, we observed that CETP deficiency and other gene polymorphisms in RCT have no impact on longevity for Japanese centenarians.
Similar content being viewed by others
Abbreviations
- ABCA1 :
-
ATP-binding cassette transporter 1
- ANOVA :
-
Analysis of variance
- apo :
-
Apolipoprotein
- CAD :
-
Coronary artery disease
- CETP :
-
Cholesteryl ester transfer protein
- HDL-C :
-
High-density lipoprotein cholesterol
- HL :
-
Hepatic lipase
- LPL :
-
Lipoprotein lipase
- PCR :
-
Polymerase chain reaction
- RCT :
-
Reverse cholesterol transport
- RFLP :
-
Restriction fragment length polymorphism
Reference
Gordon DJ, Rifkind BM (1989) High density lipoprotein-the clinical implications of recent studies. N Engl J Med 321:1311–1316
Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Jensen G, Tybjrg-Hansen A (2000) Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation 101:1907–1912
Sich D, Saidi Y, Giral P, Lagrost L, Egloff M, Auer C, Gautier V, Turpin G, Beucler I (1998) Hyperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity. Metabolism 47:965–973
Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama Y, Mabuchi H, Tall AR (1990) Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 323:1234–1238
Takahashi K, Jiang XC, Sakai N, Yamashita S, Hirano K, Bujo H, Yamazaki H, Kusunoki J, Miura T, Kussie P, Matsuzawa Y, Saito Y, Tall A (1993) A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J Clin Invest 92:2060–2064
Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, Tall AR (1996) Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 97:2917–2923
Hirano K, Yamashita S, Kuga Y, Sakai N, Nozaki S, Kihara S, Arai T, Yanagi K, Takami S, Menju M, Ishigami M, Yoshida Y, Kameda-Takemura K, Hayashi K, Matsuzawa Y (1995) Atherosclerotic disease in marked hyperalphalipoproteinemia: combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler Thromb Vasc Biol 15:1849–1856
Liu S, Schmitz C, Stampfer MJ, Sacks F, Hennekens CH, Lindpaintner K, Ridker PM (2002) A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men. Atherosclerosis 161:469–474
Brousseau ME, O'Connor JJ Jr, Ordovas JM, Collins D, Otvos JD, Massov T, McNamara JR, Rubins HB, Robins SJ, Schaefer EJ (2002) Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial. Arterioscler Thromb Vasc Biol 22:1148–1154
Hirano K, Yamashita S, Nakajima N, Arai T, Maruyama T, Yoshida Y, Ishigami M, Sakai N, Takemura K, Matsuzawa Y (1997) Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan: marked hyperalphalipoproteinemia caused by CETP gene mutation in not associated with longevity. Arterioscler Thromb Vasc Biol 17:1053–1059
Chamberlain JC, Thorn JA, Oka K, Galton DJ, Stocks J (1989) DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridemic subjects. Atherosclerosis 79:85–91
Wang XL, McCredie RM, Wilcken DE (1996) Common DNA polymorphisms at the lipoprotein lipase gene: association with severity of coronary artery disease and diabetes. Circulation 93:1339–1345
Gerdes C, Gerdes LU, Hansen PS, Faergeman O (1995) Polymorphims in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Dannish men. Circulation 92:1765–1769
Holmer SR, Hengstenberg C, Mayer B, Döring A, Löwel H, Engel S, Hense HW, Wolf M, Klein G, Riegeger AJ, Schunkert H (2000) Lipoprotein lipase gene polymorphism, cholesterol subfractions and myocardial infarction in large samples of the general population. Cardiovasc Res 47:806–812
Vohl MC, Lamarche B, Moorjani S, Prud'homme D, Nadeau A, Bouchard C, Lupien PJ, Despres JP (1995) The lipoprotein lipase HindⅢpolymorphism modulates plasma triglyceride levels in visceral obesity. Arterioscler Thromb Vasc Biol 15:714–720
Clee SM, Zwinderman AH, Engert JC, Zwarts KY, Molhuizen HO, Roomp K, Jukema JW, van Wijland M, van Dam M, Hudson TJ, et al (2001) Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103:1198–1205
Lutucuta S, Ballantyne CM, Elghannam H, Gotto AM Jr, Marian AJ (2001) Novel polymorphisms in promoter region of ATP binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res 88:969–973
Tato F, Vega GL, Grundy SM (1997) Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients: role of cholestrol-ester transfer protein and lecithin cholesteryl acyl transferase. Arterioscler Thromb Vasc Biol 17:56–63
Nishiwaki M, Ishikawa T, Ito T, Shige H, Tomiyama K, Nakajima K, Kondo K, Hashimoto H, Saitoh K, Manabe M, Miyajima E, Nakamura H (1994) Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin:cholesterol acyltransferase in high-density lipoprotein cholesterol elevation. Atherosclerosis 111:99–109
Shächter F, Fauer-Delanef L, Guenot F, Rouge H, Froguel P, Lesueur-Ginot L, and Cohen D (1994) Genetic association with human longevity at the apo E and ACE loci. Nat Genet 6:29–32
Louhija J, Miettinen HE, Kontura K, Tikkanen MJ, Miettinen TA, Tilvis RS (1994) Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians. Arterioscler Thromb 14:1084–1089
Bladbjerg EM, Andersen-Ranberg K, de Maat MP, Kristensen SR, Jeune B, Gram J, Jespersen J (1999) Longevity is independent of common variations in genes associated with cardiovascular risk. Thromb Haemost 82:1100–1105
Arai Y, Hirose N, Nakazawa S, Yamamura K, Shimizu K, Takayama M, Ebihara Y, Osono Y, Homma S (2001) Lipoprotein metabolism in Japanese centenarians-Effects of apolipoprotein E polymorphism and nutritional status. J Am Geriatr Soc 49:1434–1441
Asada T, Yamagata Z, Kinoshita T, Kariya T, Asaka A, Kakuma T (1996) Prevalence of dementia and distribution of apo E alleles in Japanese centenarians: an almost-complete survey in Yamanashi prefecture, Japan. J Am Geriatr Soc 44:151–155
Hirose N, Homma S, Arai Y, Kawamura M, Hasegawa H, Ishida H, Shimizu K, Osono Y, Homma A, Nakamura Y (1997) Tokyo Centenarian Study 4. Apolipoprotein E phenotype in Japanese centenarians living in the Tokyo metropolitan area. Jpn J Geriatr 34:267–272
Kiyohara T, Kiriyama R, Zamma S, Inazu A, Koizumi J, Mabuchi H, Chichibu K (1988) Enzyme immunoassay for cholesteryl ester transfer protein in human serum. Clin Chim Acta 271:109–118
Fumeron F, Betoulle D, Luc G, Behague I, Ricard S, Poirier O, Jemaa R, Evans A, Arveiler D, Marques-Vidal P, Bard JM, Fruchart, JC, Ducimetiere P, Apfelbaum M, Cambien F (1995) Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 96:1664–1671
Anderson JL, King GJ, Bair TL, Elmer SP, Muhlestein JB, Habashi J, Mixson L, Carlquist JF (1999) Association of lipoprotein lipase gene polymorphisms with coronary artery disease. J Am Coll Cardiol 33:1013–1020
Couture P, Otvos JD, Cupples LA, Lahoz C, Wilson PW, Schaefer EJ, Ordovas JM (2000) Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 20:815–822
Inazu A, Jiang XC, Haraki T, Yagi K, Kamon N, Koizumi J, Mabuchi H, Takeda R, Takata K, Moriyama Y, Doi M, Tall AR (1994) Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest 94:1872–1882
Goto A, Sasai K, Suzuki S, Fukutomi T, Ito S, Matsushita T, Okamoto M, Suzuki T, Itoh M, Okumura-Noji K, Yokoyama S (2000) Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography. Atherosclerosis 159:153–163
Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, Lahoz C, Coltell O, Wilson PW, Schaefer EJ. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 20:1323–1329
Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, et al (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Med 22:336–345
Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, et al (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Med 22:347–351
Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denefle P, et al (1999) Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22:352–355
Iida A, Saito S, Sekine A, Kitamura Y, Kondo K, Mishima C, Osawa S, Harigae S, Nakamura Y (2001) High-density single-nucleotide polymorphism (SNP) map of the 150-kb region corresponding to the human ATP-binding cassette transporter A1. J Hum Genet 46:522–528
Acknowledgements
We sincerely thank the centenarians and their family members for their time and assistance. We could not have carried out this study without their kind cooperation. This study was partially supported by a grant from the Ministry of Health and Welfare for the Scientific Research Project for Longevity and a grant for studying the sociomedical background of centenarians (Principal investigator, Nobuyoshi Hirose) as well as aid for research from Keio Health Consulting Center. We wish to thank to Dr. Mitsuru Murata, Keio University School of Medicine, for his assistance in statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arai, Y., Hirose, N., Yamamura, K. et al. Deficiency of choresteryl ester transfer protein and gene polymorphisms of lipoprotein lipase and hepatic lipase are not associated with longevity. J Mol Med 81, 102–109 (2003). https://doi.org/10.1007/s00109-002-0407-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-002-0407-6